CADI-R307

CADI-R307 is a discovery-stage therapeutic program developed by Bio-Modeling Systems (BMSystems) targeting disorders of the Central Nervous System (CNS) and Peripheral Nervous System (PNS). The program utilizes BMSystems' proprietary CADI™ (Computer-Assisted Deductive Integration) platform, which employs a heuristic biological modeling approach to identify novel therapeutic targets and mechanisms. By integrating diverse biological data, CADI-R307 aims to uncover systemic intervention points for complex neurological conditions that are often resistant to traditional reductionist drug discovery methods. While specific molecular targets for R307 are not publicly disclosed, the program focuses on the complex interactions within the neuro-immune or neuro-metabolic axes characteristic of CNS and PNS pathologies.